42 /100
MEDIUM RISK
Score updated Jul 14, 2026

ARDT — Ardent Health, Inc. Dilution Risk Tracker

Track ARDT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ARDT — Get alerts when the score changes →

As of July 14, 2026, Ardent Health, Inc. (ARDT) has a DilutionWatch DilutionScore of 42/100, rated MEDIUM dilution risk. Ardent Health, Inc. has a market capitalization of $1.32B, 143.35M shares outstanding, 136 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
80
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ARDT.
🔔 Track ARDT — Get forecast alerts →

💹 Market Data

Market Cap$1.32B
Shares Outstanding143.35M
Float24.17M
Cash$609.69M
Debt$1.11B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 1.2% shares (2026Q1 vs prior)
136 institutional holders · 108.98M shares
#1 CHAI TRUST CO LLC 77.25M shares
#2 Ventas, Inc. 9.34M shares
#3 GOLDENTREE ASSET MANAGEMENT LP 2.30M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest4.49M
Days to Cover7.5
% of Float18.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Apr 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for ARDT Shareholders

Ardent Health, Inc. (ARDT) has a DilutionScore of 42/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for ARDT shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for ARDT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ARDT alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track ARDT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ARDT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ARDT
📊 ARDT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ARDT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.